Through Second Genome’s proprietary platform, we are turning microbial genetics into medicines. Built with innovative technologies, including machine-learning analytics, customized protein engineering techniques, phage library screening, mass spec analysis and CRISPR, the platform enables Second Genome to identify genes and biomarkers, find bacterial proteins of interest and identify human drug targets. By coupling these insights with traditional drug development approaches, we, and our strategic partners, are able to progress development of therapies and companion diagnostics for wide-ranging diseases.

SG KnowledgeBase is a proprietary database that organizes -omics data and clinical metadata for systematic mining AWS: Amazon Web Services; MS: Mass Spectrometry.